Brief: Moonlake Prices Offering Of 9 Million Class A Shares At $20/Share
24/06/2026 04:09
BRIEF-Moonlake Prices Offering Of 9 Million Class A Shares At $20/Share June 23 (Reuters) - MoonLake Immunotherapeutics MLTX.O:
MOONLAKE IMMUNOTHERAPEUTICS ANNOUNCES PRICING OF UPSIZED $200 MILLION PUBLIC OFFERING
MOONLAKE: PRICES OFFERING OF 9 MILLION CLASS A SHARES AT $20 PER SHARE
Source text: ID:nGNX7Vg78G
Further company coverage: MLTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial